[go: up one dir, main page]

ECSP003694A - Kit combinado para el tratamiento de la malaria - Google Patents

Kit combinado para el tratamiento de la malaria

Info

Publication number
ECSP003694A
ECSP003694A EC2000003694A ECSP003694A ECSP003694A EC SP003694 A ECSP003694 A EC SP003694A EC 2000003694 A EC2000003694 A EC 2000003694A EC SP003694 A ECSP003694 A EC SP003694A EC SP003694 A ECSP003694 A EC SP003694A
Authority
EC
Ecuador
Prior art keywords
treatment
amino
day
malaria
furanone
Prior art date
Application number
EC2000003694A
Other languages
English (en)
Inventor
Ramesh Chandra Gupta
Francis Joseph Pinto
Swati Ajay Piramal
Ram Pratap
Amiya Prasad Bhaduri
Harsh Pati Thapliyal
Sunil Kumar Puri
Guru Prasad Dutta
Anil Kumar Dwivedi
Satyawan Singh
Pratina Srivastava
Vikash Chandra Pandey
Sudhir Srivastava
Shio Kumar Singh
Jagdishwar Sahai Srivastava
Omkar Prasad Asthana
Original Assignee
Nicholas Piramal India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd filed Critical Nicholas Piramal India Ltd
Publication of ECSP003694A publication Critical patent/ECSP003694A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Un estuche de combinación para el tratamiento del paludismo producido por Plasmodium vivax (p.vivax), que tiene dosis individuales de un agente antipalúdico, 3-[1-[[4-[(6-metoxi-8-quinolinil)amino]pentil}amino}etilideno]-dihidro-2-(3H)furanona (I) en forma de cápsulas; dosis individuales del agente antipalúdico cloroquina en forma de comprimidos; y material de instrucciones para la administración de los dos fármacos antipalúdicos. El estuche de combinación es particularmente adecuado para un régimen de tratamiento de 6 días, en el que el tratamiento se consigue mediante cinco comprimidos que contienen 500 mg de fosfato de cloroquinina (equivalentes a 300 mg de base), debiendo tomarse tres el d{ia uno y uno cada uno de los días dos y tres; y cinco cápsulas que contienen 25 mg de 3-[1-[[4-[(6-metoxi-8-quinolinil) amino]pentil]amino}etilideno]-dihidro-2(3H)furanona (I), debiendo tomarse una cada uno de los dias dos a seis.
EC2000003694A 2000-05-31 2000-10-05 Kit combinado para el tratamiento de la malaria ECSP003694A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31

Publications (1)

Publication Number Publication Date
ECSP003694A true ECSP003694A (es) 2002-01-25

Family

ID=11097250

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2000003694A ECSP003694A (es) 2000-05-31 2000-10-05 Kit combinado para el tratamiento de la malaria

Country Status (28)

Country Link
US (1) US7404962B1 (es)
EP (1) EP1292306B1 (es)
JP (1) JP2004505017A (es)
KR (1) KR20030025926A (es)
AP (1) AP1435A (es)
AR (1) AR028458A1 (es)
AT (1) ATE314848T1 (es)
AU (2) AU2001228790B2 (es)
BR (1) BR0005247A (es)
CA (1) CA2413775C (es)
CR (1) CR6835A (es)
CZ (1) CZ296875B6 (es)
DE (2) DE60025403T2 (es)
DK (1) DK1292306T3 (es)
EC (1) ECSP003694A (es)
ES (1) ES2200729T3 (es)
GT (1) GT200000187A (es)
HK (1) HK1052467B (es)
HN (1) HN2001000118A (es)
HU (1) HUP0301925A3 (es)
MX (1) MXPA02011883A (es)
NO (1) NO324774B1 (es)
OA (1) OA12276A (es)
PE (1) PE20011319A1 (es)
PL (1) PL200748B1 (es)
SV (1) SV2002000201A (es)
WO (1) WO2001091535A2 (es)
ZA (1) ZA200209726B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009527478A (ja) * 2006-02-16 2009-07-30 ザ マクレーン ホスピタル コーポレーション パーキンソン病の治療のための方法と組成物
WO2010065932A1 (en) * 2008-12-05 2010-06-10 Designmedix, Inc. Modified chloroquines with single ring moiety or fused ring moiety
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
SG45193A1 (en) * 1992-02-07 1998-01-16 Ciba Geigy Ag Antimalarial synergistic compositions containing benflumetol

Also Published As

Publication number Publication date
AP2002002672A0 (en) 2002-12-31
HUP0301925A3 (en) 2009-03-30
OA12276A (en) 2006-05-10
SV2002000201A (es) 2002-10-24
DE00993875T1 (de) 2004-04-15
ES2200729T3 (es) 2006-07-16
ZA200209726B (en) 2004-03-10
DE60025403T2 (de) 2006-08-24
ATE314848T1 (de) 2006-02-15
HK1052467B (en) 2006-03-10
CA2413775C (en) 2009-08-25
HK1052467A1 (en) 2003-09-19
HN2001000118A (es) 2001-10-29
CR6835A (es) 2007-04-26
NO324774B1 (no) 2007-12-10
AU2001228790B2 (en) 2007-02-01
AR028458A1 (es) 2003-05-07
CZ20024071A3 (cs) 2003-04-16
AP1435A (en) 2005-06-21
PL200748B1 (pl) 2009-02-27
ES2200729T1 (es) 2004-03-16
JP2004505017A (ja) 2004-02-19
CZ296875B6 (cs) 2006-07-12
CA2413775A1 (en) 2001-12-06
PE20011319A1 (es) 2002-03-02
BR0005247A (pt) 2002-02-13
EP1292306B1 (en) 2006-01-04
GT200000187A (es) 2002-04-18
NO20025765L (no) 2003-01-08
US7404962B1 (en) 2008-07-29
NO20025765D0 (no) 2002-11-29
EP1292306A2 (en) 2003-03-19
AU2879001A (en) 2001-12-11
MXPA02011883A (es) 2004-05-17
HUP0301925A2 (hu) 2003-09-29
DK1292306T3 (da) 2006-05-22
PL372718A1 (en) 2005-07-25
WO2001091535A2 (en) 2001-12-06
DE60025403D1 (de) 2006-03-30
WO2001091535A3 (en) 2002-07-04
WO2001091535B1 (en) 2002-10-31
KR20030025926A (ko) 2003-03-29

Similar Documents

Publication Publication Date Title
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
AR057152A1 (es) Sistema terapeutico transdermico
ES2571703T3 (es) Formulaciones de oxicodona de una vez al día
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
CO5700707A2 (es) Productos farmaceuticos
ES2157881T3 (es) Metanosulfonato de paroxetina.
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
FI3573620T3 (fi) Koostumuksia kohonneen verenpaineen hoitamiseksi
ATE358477T1 (de) Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat
CO5540294A2 (es) Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen
ECSP003694A (es) Kit combinado para el tratamiento de la malaria
AR032642A1 (es) Composiciones quimioterapicas de paclitaxel en microemulsion con mayor biodisponibilidad oral.
CO4920200A1 (es) Empaques farmaceuticos para ayudar o aumentar el cumplimien- to en la administracion de un regimen complejo de droga por via oral y metodos para su utilizacion
MY146988A (en) Fexofenadine suspension formulation
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
AR043370A1 (es) Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -droga
CO5271706A1 (es) Unidad de dosis de mirtazapina para el tratamiento de transtornos del sueno
ES2188513T3 (es) Utilizacion de desoxipeganina para el tratamiento de la drogodependencia.
CO5640069A2 (es) Forma de dosificacion oral de mesilato de saquinavir
DK1476160T3 (da) Farmaceutisk sammensætning af artesunat og mefloquin til behandling af malaria
TNSN05334A1 (en) A combination kit in the treatment of malaria
TNSN02095A1 (en) A combination kit used in the treatment of malaria
RU2005101874A (ru) Синергетическое взаимодействие абакавира и аловудина